Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000899243-22-035449

Chief Financial Officer sold 10,000 shares at $56.72 ($567,200)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gordon Stephen Chief Financial Officer 2022-11-07 Option exercise +728 $2.21 $1,609 6,442 D: show line 1 in the form
Gordon Stephen Chief Financial Officer 2022-11-07 Option exercise +9,272 $16.14 $149,650 15,714 D: show line 2 in the form
Gordon Stephen Chief Financial Officer 2022-11-07 Sale −10,000 $56.72 $567,200 5,714 D: show line 3 in the form
Open-market sales · 10,000 sh · avg $56.72 · $567,200

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Gordon Stephen Chief Financial Officer 2022-11-07 Option exercise · Stock Option (Right to Buy) −728 0 D: show line 4 in the form
Gordon Stephen Chief Financial Officer 2022-11-07 Option exercise · Stock Option (Right to Buy) −9,272 40,728 D: show line 5 in the form
Loading xslF345X03/doc4.xml…